Pharma Analytical Conference Agenda

Agenda - 8th August 2019

Plenary Session
Keynote Address: Government Initiatives to Support Pharma R&D- Long Term Innovation Strategy
Panel Discussion: Market Overview: Examining Trends in The Indian and Global Pharma Market
Networking Break
Tracks
Pharma Analytical Conference Impurity Profiling Workshop - Elemental Impurities Aseptic Processing And Sterile Manufacturing Workshop
Shelf life prediction of drug substances and drug products by kinetic modeling and simulation Panel Discussion: Examining and analyzing current trends in Impurity profiling and its scope in depth Cross-Disciplinary Perspectives on Innovative Containment Strategies, Aseptic Processing and Sterile Manufacturing
SCIEX LC-MS/MS based solutions for various Qual and Quant workflows in Pharma/Small Molecules Application Stability and Forecasted Shelf Life of Drugs Impact of Pharma Environment and Water Quality on Formulation
Networking and Lunch Break
Exploring and maximizing the potential of nanotechnology drug delivery platforms in new therapeutic and diagnostic areas Elemental impurity profile overview Principles of Sterilization and Disinfection
Overview on ICHQ3D, Delamination and Leachables in Pharmaceuticals Analysing Different Facility Designs for Sterile Product Manufacturing
Impact of DMF Queries on ANDA Approval Process: Possible Way Out Risk Assessment and Control of Elemental Impurities
High Tea & Networking
Panel Discussion: Advancements in Formulations and Drug Delivery Systems: Technologies and Platforms Genotoxic Impurity Profile Overview Challenges of Visual Inspection
Closing Remarks by the Chairperson
Networking and End of Conference

Agenda - 9th August 2019

Pharma Analytical Conference Impurity Profiling Workshop - Elemental Impurities Aseptic Processing And Sterile Manufacturing Workshop
Keynote Address Latest Updates on Manufacturing Exports in India Panel Discussion: Extractables and Leachables Regulatory Standards and Current Updates
Scalability and Optimization Solutions for Evolving API Manufacturing in India Genotoxic Impurities in Pharmaceuticals Environmental Monitoring
Networking Break
Evolving Regulatory Ecosystem of India Pharma Industry The Story of Genotoxic Impurities in Sartans and their Control Strategy Environmental Monitoring(Continued)
Tech Transfer and Optimization of with Pharmaceutical Product Lifecycle Management In Silico Assessment of Genotoxic Impurities Under the ICH M7 Guideline Process Simulations for Aseptic Processing
Networking and Lunch Break
Panel Discussion: The Changing API Industry in India Drug Product Quality and Impact of Extractable & Leachable Impurities Preventive Management: Contamination, Microbiology and Disinfection
Closing Remarks by the Chairperson
Networking and End of Conference